XML 27 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2012
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]  
Supplemental Information, Balance Sheets

 

    December 31,  
(U.S. dollars in thousands)   2011     2012  
a. Other assets:                
Deferred costs*   $ 1,558     $ 89  
Institutions     375       542  
State of Israel (see Note 6a)     1,296       2,400  
Restricted deposit     208       298  
Prepaid expenses     235       251  
Sundry     165       106  
    $ 3,837     $ 3,686  

 

* Manufacturing costs of inventory, paid by Pfizer, but not delivered.

 

(U.S. dollars in thousands)

  b. Accounts payable and accruals - other:

 

Payroll and related expenses   $ 1,108     $ 1,748  
Provision for vacation     1,221       1,453  
Accrued expenses     2,327       2,032  
Royalties payable     89       1,560  
Liability in connection with collaboration operation- current portion     1,322       3,122  
Property and equipment suppliers     1,473       1,136  
    $ 7,540     $ 11,051  

 

 
Supplemental Information, Income Statement
    Year ended December 31,  
    2010     2011     2012  
(U.S. dollars in thousands)                  
c. Revenues:                        
Deferred revenues from the license and supply agreement with Pfizer   $ 4,563     $ 4,563     $ 4,563  
Milestone payment (see note 2)                     25,000  
Revenues from selling products     2,079       3,823       5,307  
    $ 6,642     $ 8,386     $ 34,870